Search or choose
Find the right test or package.
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately improving pati...
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately impr...
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately improving patient management and care.
t(14;20)(q32;q12) IGH/MAFB includes t(14;20)(q32;q12) IGH/MAFB.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.